LCID
Lucid Group, Inc.
LCID offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
OPLN
OPENLANE, Inc.
OPLN has the edge over LCID overall, supported by lower modeled downside.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
OPLN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Strong | |
| Healthy |
OPLN's revenue, cash flow and balance sheet are currently healthy, but its profitability is under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
OPLN PE Valuation
OPLN has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
OPLN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for OPLN, with profitability holding steady.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID has the edge over OPLN on earnings, with more consistent year-over-year improvement.
OPLN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.66 | — |
| Q3 2026 | -$0.74 | -185% |
| Q2 2026 | -$0.85 | -215% |
| Q4 2021 | $0.12 | +$0.35 |
| Q3 2021 | -$0.05 | -136% |
| Q2 2021 | $0.28 | +56% |
| Q1 2021 | $0.00 | -100% |
| Q4 2020 | -$0.23 | -122% |
OPLN has swung to a loss: it lost $0.74 per share over the past year, after a profit the year before.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over OPLN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
OPLN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $561.2M | +13% |
| Q2 2026 | $554.6M | +15% |
| Q1 2026 | $527.9M | +15% |
| Q4 2025 | $494.3M | +8.6% |
| Q3 2025 | $498.4M | +11% |
| Q2 2025 | $481.7M | +12% |
| Q1 2025 | $460.1M | +11% |
| Q4 2024 | $455M | +16% |
OPLN's revenue has grown year over year for 10 quarters in a row: $561M last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 13% | +1.5 points |
| Q2 2026 | 12% | +2.3 points |
| Q1 2026 | 14% | +2.7 points |
| Q4 2025 | 8.6% | -8.8 points |
| Q3 2025 | 11% | -5.3 points |
| Q2 2025 | 9.8% | -3.1 points |
| Q1 2025 | 11% | -5.4 points |
| Q4 2024 | 17% | +2.7 points |
OPLN has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
OPLN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $83.3M | +45% |
| Q2 2026 | $39M | -32% |
| Q1 2026 | $146.5M | +32% |
| Q4 2025 | $110.8M | +493% |
| Q3 2025 | $57.6M | -47% |
| Q2 2025 | $57.4M | +134% |
| Q1 2025 | $110.7M | +27% |
| Q4 2024 | $18.7M | +117% |
OPLN has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
OPLN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +7% | +8.2M shares |
| 1 year | +16% | +17.1M shares |
| 3 years | +7.8% | +9.1M shares |
| 5 years | -3% | -3.9M shares |
| Available history | -5.6% | -7.5M shares |
OPLN has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $43.3M |
| Q2 2026 | $22.5M |
| Q1 2026 | $25.7M |
| Q4 2025 | $9.8M |
| Q3 2025 | $26.4M |
| Q2 2025 | $9.3M |
| Q1 2025 | $100,000 |
| Q4 2024 | — |
OPLN spent $101M buying back its own shares over the past year, up 183% from the year before.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
OPLN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.8x | Very low |
| Q2 2026 | 1.1x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.4x | Healthy |
| Q3 2025 | -0.3x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | 0.2x | Very low |
OPLN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
OPLN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.6 | Neutral |
| Stochastic | 32.5 | Neutral |
OPLN's weekly RSI is 48 (neutral) and its Stochastic is 33 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
OPLN PE vs Consumer Cyclical Sector
| Metric | OPLN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
OPLN has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
OPLN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.2 | 4.1% below |
| 20 week MA | $36.7 | 5.4% below |
| 50 week MA | $33.6 | 3.3% above |
| 100 week MA | $28.5 | 22% above |
| 200 week MA | $22.2 | 57% above |
OPLN has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
OPLN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.6 | $18.2 | -16% |
| 2021 | $18.2 | $15.5 | -15% |
| 2022 | $15.5 | $12.8 | -18% |
| 2023 | $12.8 | $14.8 | +16% |
| 2024 | $14.8 | $20.1 | +36% |
| 2025 | $20.1 | $31.0 | +54% |
| 2026 YTD | $31.0 | $34.7 | +12% |
OPLN has the edge over LCID on returns for 2026, with the stronger performance.